Format

Send to

Choose Destination
J Biol Chem. 2016 Jun 24;291(26):13753-61. doi: 10.1074/jbc.M116.716027. Epub 2016 Apr 29.

Hyperglycemic Conditions Prime Cells for RIP1-dependent Necroptosis.

Author information

1
From the Department of Basic and Social Sciences, Albany College of Pharmacy and Health Sciences, Albany, New York 12208.
2
the Department of Pediatrics, Columbia University, New York, New York 10032, and.
3
the Department of Pediatrics, Columbia University, New York, New York 10032, and the Departments of Pediatrics and Microbiology, New York University, New York, New York 10016 Adam.Ratner@nyumc.org.

Abstract

Necroptosis is a RIP1-dependent programmed cell death (PCD) pathway that is distinct from apoptosis. Downstream effector pathways of necroptosis include formation of advanced glycation end products (AGEs) and reactive oxygen species (ROS), both of which depend on glycolysis. This suggests that increased cellular glucose may prime necroptosis. Here we show that exposure to hyperglycemic levels of glucose enhances necroptosis in primary red blood cells (RBCs), Jurkat T cells, and U937 monocytes. Pharmacologic or siRNA inhibition of RIP1 prevented the enhanced death, confirming it as RIP1-dependent necroptosis. Hyperglycemic enhancement of necroptosis depends upon glycolysis with AGEs and ROS playing a role. Total levels of RIP1, RIP3, and mixed lineage kinase domain-like (MLKL) proteins were increased following treatment with high levels of glucose in Jurkat and U937 cells and was not due to transcriptional regulation. The observed increase in RIP1, RIP3, and MLKL protein levels suggests a potential positive feedback mechanism in nucleated cell types. Enhanced PCD due to hyperglycemia was specific to necroptosis as extrinsic apoptosis was inhibited by exposure to high levels of glucose. Hyperglycemia resulted in increased infarct size in a mouse model of brain hypoxia-ischemia injury. The increased infarct size was prevented by treatment with nec-1s, strongly suggesting that increased necroptosis accounts for exacerbation of this injury in conditions of hyperglycemia. This work reveals that hyperglycemia represents a condition in which cells are extraordinarily susceptible to necroptosis, that local glucose levels alter the balance of PCD pathways, and that clinically relevant outcomes may depend on glucose-mediated effects on PCD.

KEYWORDS:

Fas ligand; apoptosis; diabetes; glucose; hyperglycemia; ischemia; necroptosis; necrosis (necrotic death); programmed cell death; tumor necrosis factor (TNF)

PMID:
27129772
PMCID:
PMC4919457
DOI:
10.1074/jbc.M116.716027
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center